SCHEMBL7981603

SCHEMBL7981603

Cc1cc(C)c(NC(=O)c2ccc3c(c2)nc(N)c2cncn23)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 18/20 0.50
PKM P14618 1/20 0.43
NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983570 0.85 LCK (0.65) LCK
SCHEMBL7987206 0.74 LCK (0.65) LCK
SCHEMBL31325831 0.71 GABRP (0.40) LCK
SCHEMBL31136583 0.71 LCK (0.45) LCK
SCHEMBL31137728 0.69 LCK (0.58) LCK
SCHEMBL31680606 0.69 PKM (0.68) LCKPKM
SCHEMBL31040881 0.68 FGFR1 (0.42) LCK
SCHEMBL773174 0.68 HDAC1 (0.55) LCKPKM
Hydrochloric Acid SCHEMBL31137004 0.67 FGFR1 (0.41) LCK
SCHEMBL30899540 0.67 LCK (0.44) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed